The Net Margin of Adc Therapeutics Ltd (ADCT) is
-175.31%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date |
Value |
| 2025-12-31 |
-175.31%
|
| 2024-12-31 |
-222.83%
|
| 2023-12-31 |
-345.11%
|
| 2022-12-31 |
-74.23%
|
| 2021-12-31 |
-678.47%
|
| 2020-12-31 |
-678.20%
|
| 2019-12-31 |
-5065.22%
|
| 2018-12-31 |
-11190.91%
|
| 2017-12-31 |
-4994.44%
|
| Ticker |
Name |
Value |
|
GNRO.PA
|
Geneuro SA
|
-111.59%
|
|
CGEM
|
Cullinan Therapeutics, Inc.
|
-346.20%
|
|
KURA
|
Kura Oncology, Inc.
|
-412.95%
|
|
RLF.SW
|
Relief Therapeutics Holding SA
|
-203.39%
|
|
VBIV
|
VBI Vaccines Inc
|
-1069.29%
|
|
ALVR
|
Allovir Inc
|
-14023.53%
|
|
CCCC
|
C4 Therapeutics, Inc.
|
-292.08%
|
|
KYMR
|
Kymera Therapeutics, Inc.
|
-794.04%
|
|
MCRB
|
Seres Therapeutics, Inc.
|
721.93%
|
|
OBSV
|
Obseva SA
|
-290.25%
|
|
PRLD
|
Prelude Therapeutics Incorporated
|
-819.59%
|
|
ZYME
|
Zymeworks Inc.
|
-76.56%
|
|
ALEC
|
Alector, Inc.
|
-679.16%
|
|
KRON
|
Kronos Bio LLC
|
-874.08%
|
|
KRYS
|
Krystal Biotech, Inc.
|
52.64%
|
|
FPRX
|
Five Prime Therapeutics Inc
|
-639.91%
|
|
MYOV
|
Myovant Sciences Ltd
|
-89.18%
|
|
ACIU
|
AC Immune AG
|
-1971.65%
|
|
BCAB
|
Bioatla Inc
|
-2980.35%
|
|
DMTK
|
DermTech Inc
|
-659.57%
|
|
BSLN.SW
|
Basilea Pharmaceutica AG Allschwil
|
17.32%
|
|
IDIA.SW
|
Idorsia Ltd
|
-50.64%
|
|
MOLN.SW
|
Molecular Partners AG
|
-1087.38%
|
|
NRIX
|
Nurix Therapeutics, Inc.
|
-314.90%
|
|
RCUS
|
Arcus Biosciences, Inc.
|
-142.91%
|
|
GBIO
|
Generation Bio Co
|
-661.91%
|
|
INO
|
Inovio Pharmaceuticals Inc
|
-130005.97%
|
|
PAND
|
Pandion Therapeutics Inc
|
-2262.36%
|
|
CRSP
|
CRISPR Therapeutics AG
|
-16569.77%
|
|
CYTK
|
Cytokinetics, Incorporated
|
-891.60%
|
|
DCPH
|
Deciphera Pharmaceuticals Inc
|
-119.34%
|